Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-06-27T09:54:33+0100
I'm a little template short and blank. I link to void and keep hidden out.
2024-06-27T09:54:33+0100
Neuren stands out with the only FDA-approved treatment for Rett syndrome. With high margins, strong operating leverage, and a promising clinical pipeline, Neuren is poised for substantial growth.
2024-06-18T01:55:57+0100
A short description of biotech stocks, followed by seven of the largest ASX biotech shares to watch in 2023. These stocks are chosen for their market size on the ASX.
2023-09-27T20:42:05+0100
A short description of defensive stocks, and five of the best defensive stocks to watch in 2023. These companies have been considered due to their FTSE 100 status, alongside histories of stable returns through volatile periods.
2023-08-31T22:41:04+0100